| Investigating Precision Medicine in the Adjuvant Setting in Biliary Tract Cancer (NCT07745296) | UNICANCER | 2027-01-02 |
| Antibody-based PET Imaging and Treatment Response in Breast Cancer Treated With an Antibody-drug Conjugate. (NCT07294430) | UNICANCER | 2026-12-31 |
| Study Aiming to Test Whether Non-invasive Liquid Biopsies Can Safely Reduce Invasive Surveillance Methods in Lynch Syndrome (NCT07360834) | UNICANCER | 2026-12-01 |
| Study to Evaluate the Efficacy of Zanzalintinib in the Treatment of Relapsed or Metastatic Adenoid Cystic Carcinomas of the Head and Neck (NCT07682675) | UNICANCER | 2026-10-01 |
| Rising ctDNA to Tailor Endocrine Therapy Switch in Patients With ER+/HER2- Metastatic Breast Cancer. (NCT07717450) | UNICANCER | 2026-09-25 |
| Clinical Trial Evaluating the Biological Activity of a New Drug Identified as Prifetrastat (PF-07248144), Combined With Fulvestrant for the Treatment of Patients With Hormone Receptor Positive (HR+) and HER2 Negative (HER2-) Breast Cancer Extended to Other Organs. (NCT07340619) | UNICANCER | 2026-09-18 |
| Testing Two Different Drugs (Sacituzumab-govitecan and Trastuzumab-deruxtecan) Combinations Prescribed in an Alterning Pattern to Patients With Metastatic or Locally Advanced Triple-negative Breast Cancer (NCT07151586) | UNICANCER | 2026-09-01 |
| SPECT-CT Guided ELEctive Contralateral Neck Treatment in Lateralized Oropharyngeal Cancer (NCT07241273) | UNICANCER | 2026-09-01 |
| Blood Biomarkers Based Screening for HPV-driven OPC (NCT06528353) | UNICANCER | 2026-09-01 |
| Testing Ivonescimab in Combination With Chemotherapy in Patients With Metastatic Colorectal Cancers Without Liver Metastases (NCT07359456) | UNICANCER | 2026-08-31 |
| Immunotherapy Without Chemotherapy for Advanced Lung Cancer Patients With High PD-L1 Levels (NCT07360743) | UNICANCER | 2026-07-30 |
| Study Evaluating Two Treatment Strategies for Rectal Cancer in Patients ≥75 Years Old (NCT07118800) | UNICANCER | 2026-07-24 |
| Personalizing Chemotherapy Selection After Surgery for Patients With Stage III Colorectal Cancer Using a Blood Test (NCT07340567) | UNICANCER | 2026-07-20 |
| Skipping Hormone Therapy in Low-Risk Early Breast Cancer (NCT07661927) | UNICANCER | 2026-07-06 |
| Immunotherapy Master Trial for Advanced Cancers (NCT07431073) | UNICANCER | 2026-07-01 |
| Liver-directed Chemotherapy After Surgery of Liver Metastases of Colorectal Cancer in Patients With High Risk of Recurrence of Their Disease (NCT07284394) | UNICANCER | 2026-07-01 |
| Optimising Adjuvant Chemotherapy Prescription in Young Patients With Hormone-dependent Breast Cancer Using Genomic Tests (NCT07106632) | UNICANCER | 2026-06-26 |
| Evaluation of an Online Intervention to Educate Women at High Risk of Breast Cancer on How to Help Reduce Their Risk. (NCT07120087) | UNICANCER | 2026-02-19 |
| Neo-adjuvant Immunotherapy Master Trial for Localized Cancers (NCT07262489) | UNICANCER | 2026-01-21 |
| Neo-adjuvant Immunotherapy in Patients With Localized Melanoma (NCT07230613) | UNICANCER | 2026-01-12 |
| Chemotherapy De-escalation in HR +, HER2-, Intermediate-risk Early Breast Cancer Treated With Adjuvant Ribociclib (NCT07237256) | UNICANCER | 2025-12-18 |
| Testing Ivonescimab in Combination With Chemotherapy in Advanced or Metastatic Gastric/Gastroesophageal Adenocarcinoma (NCT06846346) | UNICANCER | 2025-11-20 |
| Durvalumab and Tremelimumab With or Without Hepatic Arterial Infusion of Chemotherapy in Hepatocellular Carcinoma (NCT06904170) | UNICANCER | 2025-11-14 |
| Optimal Methods to Characterize ADC Resistance in Solid Tumors and Identify Clinically Useful Biomarkers (NCT07259226) | UNICANCER | 2025-11-14 |
| Clinical Trial Evaluating the Activity of Zanidatamab for the Treatment of Patients With Solid Tumors With an Alteration of the HER2 Gene. (NCT07192068) | UNICANCER | 2025-10-30 |
| Testing Ivonescimab Versus FOLFOX in Advanced Biliary Tract Cancer Patients (NCT06529718) | UNICANCER | 2025-10-09 |
| Arm Swelling Occurence in Breast Cancer Patients With Nodal Radiotherapy: Impact of Informing Them of AI-predicted Risk (NCT07187726) | UNICANCER | 2025-10-07 |
| Detecting Tumor DNA in the Blood of HR+/HER2-low Metastatic Breast Cancer Patients to Find Candidates for T-DXd Therapy (NCT06680596) | UNICANCER | 2025-07-30 |
| Study Evaluating the Efficacy and Safety of Darolutamide and Stereotactic Dose Escalated Radiotherapy in Patients With Localized Prostate Cancer and High-risk Features of Relapse (NCT06625970) | UNICANCER | 2025-04-10 |
| Efficacy of Pemigatinib in Patients With Solid Tumors Characterized by an Alteration of the Gene FGFR in Tumor Cells (NCT06653777) | UNICANCER | 2025-03-27 |
| Safety of Trifluridine/Tipiracil in Patients With Dihydropyrimidine Dehydrogenase Deficiency Diagnosed With Metastatic Colorectal or Gastroesophageal Cancer (NCT06245356) | UNICANCER | 2025-03-21 |
| Capecitabine Plus Pembrolizumab in Patients With Triple Negative Breast Cancer After Chemo-immunotherapy and Surgery (NCT05973864) | UNICANCER | 2025-03-11 |
| Interest of Post-operative Chemotherapy in Patients With Localised Uterine Leiomyosarcoma Suspected of Having a High Risk of Recurrence Based on a Biological Test Performed on the Tumour (NCT06524583) | UNICANCER | 2025-01-27 |
| Decreasing Treatment for Metastatic HER2-Positive Breast Cancer With Undectable Cancer Levels in Blood Tests. (NCT06450314) | UNICANCER | 2025-01-25 |
| Dose Individualization of Chemotherapy in Patients With Gastrointestinal Cancers Lacking a Specific Liver Enzyme (NCT06475352) | UNICANCER | 2025-01-20 |
| Pembrolizumab and Chemotherapy Treatment or no Treatment Guided by the Level of TILs in Resected Early-stage TNBC (NCT06078384) | UNICANCER | 2024-12-27 |
| Telemonitoring Platform "CUREETY TECHCARE" vs Standard of Care for mTBNC Patients Initiating a First-line Treatment (NCT06505018) | UNICANCER | 2024-07-25 |
| Dostarlimab for Locally Advanced or Metastatic Cancer (Non-colorectal/Non-endometrial) With Tumor dMMR/MSI (NCT06333314) | UNICANCER | 2024-07-23 |
| Personalized Medicine for Advanced Biliary Cancer Patients (NCT05615818) | UNICANCER | 2024-07-18 |
| SURVEILLE-HPV: Evaluation of HPV16 Circulating DNA as Biomarker to Detect the Recurrence, in Order to Improve Post Therapeutic Surveillance of HPV16-driven Oropharyngeal Cancers (NCT05582122) | UNICANCER | 2024-04-03 |
| Capecitabine, Tucatinib, and Intrathecal Trastuzumab for Breast Cancer Patients With Leptomeningeal Disease (NCT05800275) | UNICANCER | 2023-12-18 |
| Testing Immunotherapy for Patients With Liver Cancer and Moderately Altered Liver Functions (NCT05622071) | UNICANCER | 2023-10-12 |
| Safety and Efficacy Analysis of an Antibody Associated With a Chemotherapy for Patients With a Triple Negative Metastatic Breast Cancer (NCT05552001) | UNICANCER | 2023-10-05 |
| A Clinical-biological Prospective Cohort of Patients With BRAFV600E-mutated Metastatic Colorectal Cancer (NCT05639413) | UNICANCER | 2023-07-24 |
| Oxaliplatin ± Nivolumab in Combination With Trifluridine/Tipiracil or 5-fluorouracile in Frail Patients With Advanced, Recurrent or Metastatic Gastric, Oesophageal or Gastroesophageal Junction Cancer (NCT05476796) | UNICANCER | 2023-06-23 |
| Durvalumab Maintenance After Thoracic Chemoradiotherapy in Frail Small Cell Lung Cancer Patients Whose Disease is Limited to the Thorax (NCT05617963) | UNICANCER | 2023-03-24 |
| Deescalation of Endocrine Therapy Duration in Women With HR+ HER2- Breast Cancer at Very Low Risk (NCT05297617) | UNICANCER | 2022-10-12 |
| Binimetinib Encorafenib Pembrolizumab +/- Stereotactic Radiosurgery in BRAFV600 Melanoma With Brain Metastasis (NCT04074096) | UNICANCER | 2022-09-05 |
| TARGETed Therapy Drug MONITOring in DIGestive Oncology (NCT05443087) | UNICANCER | 2022-08-29 |
| ADT +/- Darolutamide in de Novo Metastatic Prostate Cancer Patients With Vulnerable Functional Ability (PEACE6-Vulnerable) (NCT04916613) | UNICANCER | 2022-04-19 |
| Study Comparing the Standard Administration of IO Versus the Same IO Administered Each 3 Months in Patients in Response After 6 Months of Standard IO (NCT05078047) | UNICANCER | 2022-03-08 |
| Treatment With Tucatinib in Patients With an Isolated Brain Progression of a Metastatic Breast Cancer (NCT05041842) | UNICANCER | 2021-12-17 |
| Study on the Efficacy of Treatment by Radiotherapy and Pembrolizumab in Newly Diagnosed Metastatic Head & Neck Cancers (NCT04747054) | UNICANCER | 2021-12-01 |
| Patient's Choice in the Reduction of Their Treatment in Women Over 65 Year With Breast Cancer (NCT05058196) | UNICANCER | 2021-10-01 |
| Comparison of Oral Cyclophosphamide vs Doxorubicin in ≥65 Years Old Advanced or Metastatic Soft Tissue Sarcoma Patients (NCT04757337) | UNICANCER | 2021-06-18 |
| Sequences Of REGorafenib And Trifluridine/Tipiracil in Patients With Metastatic Colorectal Cancer (NCT04450836) | UNICANCER | 2020-11-23 |
| Efficacy of Immunotherapy Plus a Drug in Patients With Progressive Advanced Mucosal Cancer of Different Locations (NCT04357873) | UNICANCER | 2020-10-28 |
| Effectiveness Assessment of Riluzole in the Prevention of Oxaliplatin-induced Peripheral Neuropathy. (NCT03722680) | UNICANCER | 2020-10-28 |
| Prostate-cancer Treatment Using Stereotactic Radiotherapy for Oligometastases Ablation in Hormone-sensitive Patients (NCT04115007) | UNICANCER | 2020-06-23 |
| Endocrine Therapy With Abemaciclib or Chemotherapy as Initial Metastatic Treatment in ER+/HER2- Breast Cancer (NCT04158362) | UNICANCER | 2020-06-11 |
| COVID-19 Detection Test in Oncology (NCT04367870) | UNICANCER | 2020-05-23 |
| Concordance of the IHC4 Score Performed in Local or Central Laboratory to Endopredict in ER+/HER2- Breast Cancer (NCT04246606) | UNICANCER | 2020-04-24 |
| Effectiveness and Tolerance of Fentanyl Citrate in Painful Pain Induced During Diagnostic or Therapeutic Examinations in Cancer Patients (NCT03809455) | UNICANCER | 2020-02-01 |
| Combined Apalutamide, Radiotherapy, and LHRH Agonist in Prostate Cancer Patients After Prostatectomy (NCT04181203) | UNICANCER | 2020-01-09 |
| Locoregional Treatment and Palbociclib in de Novo, Treatment Naive, Stage IV ER+, HER2- Breast Cancer Patients (NCT03870919) | UNICANCER | 2019-10-23 |
| Study of DS-8201a, an Antibody Drug Conjugate for Advanced Breast Cancer Patients, With Biomarkers Analysis (NCT04132960) | UNICANCER | 2019-10-21 |
| Durvalumab, With Olaparib and Fulvestrant in Advanced ER+, HER2- Breast Cancer Patients. (NCT04053322) | UNICANCER | 2019-08-26 |
| My Personalized Breast Screening (NCT03672331) | UNICANCER | 2019-07-18 |
| Gemcitabine and Paclitaxel vs Gemcitabine Alone After FOLFIRINOX Failure in Metastatic Pancreatic Ductal Adenocarcinoma (NCT03943667) | UNICANCER | 2019-05-23 |
| Radiotherapy Omission in Low Risk Ductal in Situ Carcinoma Breast (NCT03878342) | UNICANCER | 2019-05-10 |
| Impact of Immunoscore Colon Test on Adjuvant Therapeutic Strategy in Non-Metastatic Colon Cancer (NCT03946033) | UNICANCER | 2019-05-01 |
| Oligometastases of the LIVer Treated With Chemotherapy With ou Without Extracranial Stereotactic Body Radiation Therapy in Patients With Colorectal Cancer (NCT03532204) | UNICANCER | 2019-04-15 |
| Regorafenib Combined With Irinotecan as Second-line in Patients With Metastatic Gastro-oesophageal Adenocarcinomas (NCT03722108) | UNICANCER | 2019-02-07 |
| Atezolizumab After Chemo-radiotherapy for MIBC Patients Not Eligible for Radical Cystectomy (NCT03697850) | UNICANCER | 2018-12-14 |
| Association of Radiochemotherapy and Immunotherapy for the Treatment of Unresectable Oesophageal caNcer (NCT03777813) | UNICANCER | 2018-12-05 |
| Treatment of Metastatic Castrate Resistant Prostate Cancer Patients According to Circulating Tumor Cells Kinetic (NCT03101046) | UNICANCER | 2018-11-15 |
| Mifamurtide Combined With Post-operative Chemotherapy for Newly Diagnosed High Risk Osteosarcoma Patients (NCT03643133) | UNICANCER | 2018-10-23 |
| A Patient Consensus for the Research in Supportive Care in French Cancer Care Centers: the CyPRES Project (NCT03320161) | UNICANCER | 2018-10-10 |
| Improving SUrgery of Liver Metastases: a Trial of the Arterial Chemotherapy Network (NCT03164655) | UNICANCER | 2018-07-25 |
| Standard Treatment +/- SBRT in Solid Tumors Patients With Between 1 and 5 Bone-only Metastases (NCT03143322) | UNICANCER | 2018-07-24 |
| Identifying the Predictive Factors of Response to PD-1 or PD-L1 Antagonists (NCT03412058) | UNICANCER | 2018-06-27 |
| Adjuvant Radiotherapy in Patients With Pathological High-risk Bladder Cancer (GETUG-AFU 30) (NCT03333356) | UNICANCER | 2018-04-19 |
| SAFIR-PI3K A Phase II Randomized Maintenance Trial Comparing Alpelisib and Fulvestrant Versus Chemotherapy in PIK3CA Mutated Advanced Breast Cancer (NCT03386162) | UNICANCER | 2018-03-15 |
| Study on Androgen Receptor and Triple Negative Breast Cancer (NCT03383679) | UNICANCER | 2018-03-14 |
| Evolution of the Therapeutic Care in Lung Cancer in France Since 2015 (ESME LC) (NCT03848052) | UNICANCER | 2017-10-02 |
| Investigation of Tumour Spectrum of Germline Mutations in Breast and Ovarian Cancer Genes. (NCT03246841) | UNICANCER | 2017-09-21 |